Literature DB >> 29925725

Cardiac Surgery Using Hypothermic Circulatory Arrest in a Case of Essential Thrombocythemia.

Masahide Enomoto1, Takeshi Kinoshita1, Yasuo Kondo1, Tomoaki Suzuki1, Tohru Asai1.   

Abstract

We present the case of a 61-year-old patient with a history of essential thrombocythemia (ET) who was diagnosed as having aortic valve stenosis and dilatation of his ascending aorta. His aortic valve and ascending aorta were replaced under hypothermic circulatory arrest (HCA). No clear guideline exists for preoperative, perioperative, and postoperative management of cardiac surgery using HCA for ET patients. After performing risk assessment, we prescribed preoperative aspirin therapy and postoperative care was planned as usual for cardiovascular surgery in our establishment. Unexpectedly, activated clotting time did not exceed 400 seconds, but the course of treatment was otherwise uneventful.

Entities:  

Keywords:  essential thrombocythemia; hypothermic circulatory arrest

Mesh:

Substances:

Year:  2018        PMID: 29925725      PMCID: PMC7641890          DOI: 10.5761/atcs.cr.17-00241

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  13 in total

1.  [A case report of aorto-coronary artery bypass surgery in patient with essential thrombocythemia].

Authors:  K Kohno; Y Takeuchi; A Gomi; H Nakatani; J Yamanaka
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1997-01

2.  A Novel Approach to Essential Thrombocythemia and Cardiac Surgery.

Authors:  Bradford B Smith; Gregory A Nuttall; Rajiv K Pruthi; David L Joyce; Matthew S Schuldes; Mark M Smith
Journal:  Ann Thorac Surg       Date:  2017-03       Impact factor: 4.330

3.  Cardiac surgery in a patient with essential thrombocythemia: a case report.

Authors:  B E Schölzel; H Endeman; W Dewilde; A Yilmaz; O de Weerdt; J M Ten Berg
Journal:  Neth Heart J       Date:  2010-08       Impact factor: 2.380

4.  How I treat essential thrombocythemia.

Authors:  Philip A Beer; Wendy N Erber; Peter J Campbell; Anthony R Green
Journal:  Blood       Date:  2010-11-24       Impact factor: 22.113

5.  [A case report: mitral valve replacement for the patient with essential thrombocythemia].

Authors:  Y Nonami; N Sasahashi; K Satoh; S Ogoshi; T Tamiya
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1993-09

6.  No treatment for low-risk thrombocythaemia: results from a prospective study.

Authors:  M Ruggeri; G Finazzi; A Tosetto; S Riva; F Rodeghiero; T Barbui
Journal:  Br J Haematol       Date:  1998-12       Impact factor: 6.998

7.  [A case of coronary artery bypass surgery using left internal thoracic artery and right gastroepiploic artery for a patient with essential thrombocythemia].

Authors:  T Ohto; H Shihara; Y Miyauchi; N Nakajima
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-08

8.  [A case report: coronary artery bypass grafting for the patient with essential thrombocythemia].

Authors:  J Iemura; T Sato; T Yamada; F Ando
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1991-08

9.  Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors.

Authors:  Alexandra P Wolanskyj; Susan M Schwager; Rebecca F McClure; Dirk R Larson; Ayalew Tefferi
Journal:  Mayo Clin Proc       Date:  2006-02       Impact factor: 7.616

10.  Aortic valve replacement in a young patient with essential thrombocytosis.

Authors:  Kashif Ahmed; Hunaid A Vohra; Alison Milne; Stephen M Langley
Journal:  J Cardiothorac Surg       Date:  2008-01-30       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.